Emergency management of ceftriaxone-induced Type II Kounis syndrome: A case report

头孢曲松诱发的II型Kounis综合征的紧急处理:病例报告

阅读:1

Abstract

RATIONALE: Ceftriaxone, a broad-spectrum β-lactam antibiotic, can induce severe allergic reactions such as anaphylaxis, which may lead to life-threatening type II Kounis syndrome (K-S), a variant of acute coronary syndrome triggered by allergic reactions. This case report aims to enhance the clinical understanding of ceftriaxone-induced type II K-S by presenting a detailed account of a patient's emergency management and subsequent recovery, emphasizing the importance of early recognition, intervention, and the role of nursing care in achieving a favorable outcome. PATIENT CONCERNS: A 73-year-old male with no known allergy history was admitted for cough and shortness of breath. After ceftriaxone administration, he developed chest tightness, shortness of breath, hypotension, and abdominal rash. DIAGNOSES: Type II K-S triggered by ceftriaxone-induced anaphylaxis was diagnosed. INTERVENTIONS: Immediate management included discontinuing ceftriaxone, emergency tracheal intubation, and intravenous epinephrine. Emergency coronary angiography showed no significant coronary artery stenosis. Postoperatively, the patient received antiplatelet therapy, plaque stabilization, and vasodilation in the intensive care unit. OUTCOMES: The patient's condition stabilized, tracheal intubation was removed, and he was discharged after 10 days of treatment with significant clinical improvement. LESSONS: This case emphasizes the critical importance of early recognition and management of ceftriaxone-induced type II K-S. Vigilant monitoring for allergic reactions and a multidisciplinary approach to care are essential for achieving favorable patient outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。